Anticancer Therapies – Products
Product News
Transgenomic and MD Anderson Collaborate on Circulating Tumor Cell Study using ICE COLD-PCR
Teams join forces to evaluate the use of Transgenomic’s very high sensitivity ICE COLD-PCR mutation detection technology in analysis of DNA isolated from circulating tumor cells (CTCs) in blood samples from patients with advanced cancer.
Product News
apceth and Indivumed to Develop Biomarker Platform for Targeted Cellular Therapies
Development of tissue-based biomarker strategy for the treatment of solid cancers.
Product News
Kedem Pharmaceuticals Introduces Their Sublingual Drug Delivery System
Company to participate in the World Money Show in Orlando, Fl., Booth #609, held on February 9 -12.
Product News
Simcyp Develops Virtual Laboratory Mouse for Use in Cancer and Toxicology Research
The Simcyp Mouse provides a virtual environment for evaluating drug disposition which will replace the need for some live animal testing in normal as well as transgenic mice, thus reducing and refining preclinical investigation.
Product News
New educational Program Helps the Siblings of Children with Cancer
New research published in BioMed Central’s open access journal Child and Adolescent Psychiatry and Mental Health shows that a teaching program, designed to improve the child’s knowledge about their sibling’s disease and to give them coping skills, was able to improve their adjustment and psychological well being in this early time period after diagnosis.
Product News
GeneKey Offers Genomic Analysis for Individual Cancer Patients
The company announced it has launched a personalized medicine service that empowers cancer patients and their oncology teams to develop treatment strategies based on insight into the biology of individual tumors.
Product News
New Molecular Diagnostic Test from Randox
New test enables rapid, appropriate selection of CRC patients for anti-EGFR therapy.
Product News
New Molecular Diagnostic Test from Randox
High morbidity rates make early diagnosis and therapy assignment crucial. The Randox test enables rapid, appropriate selection of colorectal cancer (CRC) patients for anti-EGFR therapy, therefore maximising drug efficacy and minimising adverse side effects to the patient.
Whitepaper
Dolomite and Clearbridge BioMedics develop revolutionary instrument for cancer detection
Product News
CureVac Presents Results of a Phase I/IIa Trial in NSCLC with CV9201 at SITC Meeting
High immune response rate of 84% in heavily pre-treated NSCLC patients.
Advertisement